A Prospective, Open-label, Nonrandomized Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Ketorolac (Primary)
- Indications Acute pain
- Focus Therapeutic Use
- Acronyms Sprix
- 16 Jan 2017 Status changed from active, no longer recruiting to completed.
- 29 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
- 01 Feb 2016 Planned End Date changed from 1 Dec 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov record.